Fingerprint
Dive into the research topics of 'Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation
Svea Böhm, Katharina Wustrau, Jana Pachlopnik Schmid, Seraina Prader, Martina Ahlmann, Joanne Yacobovich, Rita Beier, Carsten Speckmann, Wolfgang Behnisch, Marianne Ifversen, Michael Jordan, Rebecca Marsh, Nora Naumann-Bartsch, Christine Mauz-Körholz, Manfred Hönig, Ansgar Schulz, Iwona Malinowska, Melissa Hines, Kim E. Nichols, Juana Gil-Herrera
*Corresponding author for this work
- University of Hamburg
- Ulm University
- University of Zurich
- University of Münster
- Schneider Childrens Medical Center Israel
- Hannover Medical School
- University of Freiburg
- Heidelberg University
- University of Copenhagen
- Cincinnati Children's Hospital Medical Center
- Friedrich-Alexander University Erlangen-Nürnberg
- Justus Liebig University Giessen
- Martin Luther University Halle-Wittenberg
- Medical University of Warsaw
- St. Jude Children Research Hospital
- Hospital General Universitario Gregorio Marañon
- Medical College of Wisconsin
- IWK Health Centre
- Charles University
- Bielefeld University
- Goethe University Frankfurt
- University of Göttingen
- Hematology/Oncology
- Klinikum Kassel GmbH
- Technical University of Munich
- Johannes Gutenberg University Mainz
- University of Tübingen
- Utrecht University
- Princess Máxima Center for Pediatric Oncology
- Karolinska Institutet
Research output: Contribution to journal › Article › peer-review
22
Scopus
citations